Clinical and radiological characteristics of central pain in demyelinating diseases with spinal cord lesions
https://doi.org/10.21518/ms2025-023
Abstract
Introduction. Pain is a prominent feature of demyelinating diseases. The identification of potential associations between the size and localisation of demyelinating lesions in spinal cord and the development of central neuropathic pain has scientific and clinical significance.
Aim. To investigate the clinical and radiological characteristics of central neuropathic pain in demyelinating diseases affecting the spinal cord.
Materials and methods. A total of 52 patients with spinal cord involvement in multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) were examined. Participants were divided into two groups: with pain (n = 25, including 12 patients with MS and 13 with NMOSD) and without pain (n = 27, including 16 patients with MS and 11 with NMOSD). Standardized interviews were conducted, pain intensity was assessed using a 10-point Visual Analog Scale (VAS), and participants completed the DN4 questionnaire. The degree of disability was assessed using the Expanded Disability Status Scale (EDSS). For lesion localization, CNS MRI data were analyzed (MRI scanners with a field strength of ≥ 1.5 T, with imaging conducted within one year). Statistical analyses were performed using SPSS Statistics.
Results. Pain intensity was higher in patients with NMOSD compared to MS (p = 0.011). Pain was more frequent with dorsolateral localization of demyelinating lesions (p = 0.019) and was not associated with lesion size.
Conclusion. The mechanisms underlying pain syndrome in NMOSD and MS with spinal cord involvement cannot be fully explained by lesion characteristics alone and require further investigation.
About the Authors
E. V. ErmilovaRussian Federation
Elizaveta V. Ermilova - Candidate of the Degree of Cand. Sci. (Med.), Department of Nervous Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine.
11, Bldg. 1, Rossolimo St., Moscow, 119435
O. N. Voskresenskaya
Russian Federation
Olga N. Voskresenskaya - Dr. Sci. (Med.), Professor of the Department of Nervous Diseases and Neurosurgery at the N.V. Sklifosovsky Institute of Clinical Medicine.
11, Bldg. 1, Rossolimo St., Moscow, 119435
Sh. R. Nabiev
Russian Federation
Shikhmirza R. Nabiev - Head of the First Neurological Department of the Kozhevnikov Nervous Diseases Clinic of the University Clinical Hospital No. 3.
11, Bldg. 1, Rossolimo St., Moscow, 119435
References
1. Jarius S, Aktas O, Ayzenberg I, Bellmann-Strobl J, Berthele A, Giglhuber K et al. Update on the diagnosis and treatment of neuromyelitsoptica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol. 2023;270(7):3341–3368. https://doi.org/10.1007/s00415-023-11634-0.
2. Flanagan EP. Autoimmune myelopathies. Handb Clin Neurol. 2016;133:327–351. https://doi.org/10.1016/B978-0-444-63432-0.00019-0.
3. Finnerup NB, Gyldensted C, Nielsen E, Kristensen AD, Bach FW, Jensen TS. MRI in chronic spinal cord injury patients with and without central pain. Neurology. 2003;61(11):1569–1575. https://doi.org/10.1212/01.wnl.0000096016.29134.fa.
4. Ermilova EV, Voskresenskaya ON, Ospelnikova TP, Shitova AD. Clinical Features of Pain Syndrome in Demyelinating Diseases with Spinal Cord Injury. Doctor.Ru. 2022;21(4):19–23. (In Russ.) https://doi.org/10.31550/1727-2378-2022-21-4-19-23.
5. Wasner G, Lee BB, Engel S, McLachlan E. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain. 2008;131(9):2387–2400. https://doi.org/10.1093/brain/awn169.
6. Breckwoldt MO, Gradl J, Hähnel S, Hielscher T, Wildemann B, Diem R et al. Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients. J Neurol. 2017;264(2):341–349. https://doi.org/10.1007/s00415-016-8353-3.
7. Galler S, Stellmann JP, Young KL, Kutzner D, Heesen C, Fiehler J, Siemonsen S. Improved Lesion Detection by Using Axial T2-Weighted MRI with Full Spinal Cord Coverage in Multiple Sclerosis. AJNR Am J Neuroradiol. 2016;37(5):963–969. https://doi.org/10.3174/ajnr.A4638.
8. Cacciaguerra L, Sechi E, Rocca MA, Filippi M, Pittock SJ, Flanagan EP. Neuroimaging features in inflammatory myelopathies: A review. Front Neurol. 2022;13:993645. https://doi.org/10.3389/fneur.2022.993645.
9. Belova AN, Boiko AN, Belova EM. Diagnostic criteria for neuromyelitisoptica spectrum disorders. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2016;116(2-2):32–40. (In Russ.) https://doi.org/10.17116/jnevro20161162232-40.
10. Simaniv TO, Bakhtiyarova KZ, Belova AN, Goncharova ZA, Sivertseva SA, Spirin NN et al. Diagnostic criteria and treatment of neuromyelitis optica spectrum disorders (NMOSD). Neurology, Neuropsychiatry, Psychosomatics. 2023;(15):71–75. (In Russ.) https://doi.org/10.14412/2074-2711-2023-1S-71-75.
11. Breckwoldt MO, Gradl J, Hähnel S, Hielscher T, Wildemann B, Diem R et al. Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients. J Neurol. 2017;264(2):341–349. https://doi.org/10.1007/s00415-016-8353-3.
12. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162–173. https://doi.org/10.1016/S14744422(17)30470-2.
13. Finnerup NB, Jensen TS. Spinal cord injury pain-mechanisms and treatment. Eur J Neurol. 2004;11(2):73–82. https://doi.org/10.1046/j.1351-5101.2003.00725.x.
14. Li X, Xu H, Zheng Z, Ouyang H, Chen G, Lou Z et al. The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study. BMC Neurol. 2022;22(1):304. https://doi.org/10.1186/s12883-022-02841-9.
15. Okuda DT, Melmed K, Matsuwaki T, Blomqvist A, Craig ADB. Central neuropathic pain in MS is due to distinct thoracic spinal cord lesions. Ann Clin Transl Neurol. 2014;1(8):554–561. https://doi.org/10.1002/acn3.85.
16. Endo T, Spenger C, Hao J, Tominaga T, Wiesenfeld-Hallin Z, Olson L, Xu XJ. Functional MRI of the brain detects neuropathic pain in experimental spinal cord injury. Pain. 2008;138(2):292–300. https://doi.org/10.1016/j.pain.2007.12.017.
17. Rivel M, Achiron A, Dolev M, Stern Y, Zeilig G, Defrin R. Central Neuropathic Pain in Multiple Sclerosis Is Associated with Impaired Innocuous Thermal Pathways and Neuronal Hyperexcitability. Pain Med. 2021;22(10):2311–2323. https://doi.org/10.1093/pm/pnab103.
18. Finnerup NB, Sørensen L, Biering-Sørensen F, Johannesen IL, Jensen TS. Segmental hypersensitivity and spinothalamic function in spinal cord injury pain. Exp Neurol. 2007;207(1):139–149. https://doi.org/10.1016/j.expneurol.2007.06.001.
19. Li J, Tian C, Yuan S, Yin Z, Wei L, Chen F et al. Neuropathic pain following spinal cord hemisection induced by the reorganization in primary somatosensory cortex and regulated by neuronal activity of lateral parabrachial nucleus. CNS Neurosci Ther. 2023;29(11):3269–3289. https://doi.org/10.1111/cns.14258.
Review
For citations:
Ermilova EV, Voskresenskaya ON, Nabiev SR. Clinical and radiological characteristics of central pain in demyelinating diseases with spinal cord lesions. Meditsinskiy sovet = Medical Council. 2025;(3):90-95. (In Russ.) https://doi.org/10.21518/ms2025-023